Last reviewed · How we verify

NCT06631599

Effects of Trainings on Physical Performance in Soccer Players

Completed NA Last updated 8 October 2024
What this trial tests

NA trial testing Physical training in Health in 30 participants. Completed in 1 June 2024.

Timeline
1 February 2019
Primary endpoint
1 June 2024
1 June 2024

Quick facts

Lead sponsorUniversity School of Physical Education, Krakow, Poland
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationnon randomized
Designparallel
Maskingnone
Primary purposediagnostic
Enrollment30
Start date1 February 2019
Primary completion1 June 2024
Estimated completion1 June 2024
Sites1 location across Poland

Drugs / interventions tested

Conditions studied

Sponsor

University School of Physical Education, Krakow, Poland

Who can join

Eligibility, male only, with Health or Sport. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The main objective of study was to examine the effects of different trainings on physical performance in amateur soccer players at different age. Participants trained according to various training protocols aimed at improving their motor skills (strength, power, speed, efficiency). We searched for the most optimal protocol, i.e. one that most effectively improves the study of motor skills and fitness.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of Physical training

Trials testing the same drug.

Other recruiting trials for Health

Currently open trials in the same condition.

Other University School of Physical Education, Krakow, Poland trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06631599.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing